In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers

Gynecologic Oncology

Volumn 71, Issue 2, 1998, Pages 308-312

  Monk, Bradley J ^a   Alberts, David S ^c   Burger, Robert A ^a   Fanta, Paul T ^c   Hallum III, Alton V ^c   Hatch, Kenneth D ^c   Salmon, Sydney E ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; NEDAPLATIN;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOTOXICITY; DRUG EFFECT; FEMALE; GROWTH INHIBITION; HUMAN; OTOTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TUMOR GROWTH; UTERINE CERVIX CANCER; VOMITING;

EID: 0032213891     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5140     Document Type: Article

References (28)

1. Rosenberg B, Van Camp L, Krigas T. Inhibition of cell division inEscherichia coli. Nature. 205:1965;698-699.
2. Rosenberg B, Van Camp L, Trosko J E, Mansour V H. Platinum compounds: a new class of potent antitumor agents. Nature. 222:1969;385-386.
3. DiSaia P J, Creasman W T. Invasive Cervical Cancer. Clinical Gynecologic Oncology. 1993;Mosby, St. Louis. p. 58-125.
4. Alberts D S, Garcia D J. Salvage chemotherapy in recurrent or refractory squamous cell cancer of the uterine cervix. Semin Oncol. 21:1996;37-46.
5. Alberts D S, Mason-Liddil N. The role of cisplatin in the management of advanced squamous cell cancer of the cervix. Semin Oncol. 16:1989;66-78.
6. Alberts D S, Kronmal R, Baker L H, Stock-Novack D L, Surwit E A, Boutselis J G, Hannigan E V. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group study. J Clin Oncol. 5:1987;1791-1795.
7. Weiss R B, Christian M C. New cisplatin analogues in development: a review. Drugs. 46:1993;360-377.
8. Totani T, Aono K, Komura, Adachi Y. Synthesis of (glycolato-O-O. Chem Lett. 1986;492-432.
9. Sasaki Y, Shinkai T, Eguchi K, Tamura T, Obe Y, Ohmori T, Saijo N. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay. Cancer Chemother Pharmacol. 27:1991;263-270.
10. Shiratori O, Kasai H, Uchida N, Takeda Y, Totani T, Sato K. Antitumor Activity of 254-S, a Platinum Complex, in Rodents. Recent Advances in Chemotherapy. 1985;Univ. Tokyo Press, Tokyo. p. 635-637.
11. Totani T, Aono K, Adachi Y, Komura M, Shiratori O, Sato K. Bidentate Hydroxycarboxylic Acid Platinum(II) Complexes with Antitumor Activity. Marino N. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. 1988;744-748 Martinus Nijhoff, Boston.
12. Fukuda M, Shinkai T, Eguchi K, Sasaki Y, Tamura T, Obe Y, Kojima A, Oshita F, Hara K, Saijo N. Phase II study of (glycolato-O-O. Cancer Chemother Pharmacol. 26:1990;393-396.
13. Inuyama Y, Miyake H, Horiuchi M, Hayasaki K, Komiyama S, Ora K. An early phase II clinical study of cis-diammine glycolatoplatinum, 254-S, for head and neck cancers. Jpn J Cancer Chemother. 19:1992;863-869.
14. Majima H. Clinical Studies with Cisplatin Analogues, 254S, DWA2114R and NK121. Howell S B. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. 1991;345-355 Plenum, New York.
15. Leibovitz A, Liu R, Hayes C, Salmon S E. A hypoosomotic medium to disaggregate tumor cell clumps into viable and clonogenic single cells for the human tumor stem cell clonogenic assay. Int J Cell Cloning. 1:1983;478-485.
16. Salmon S E, Liu R, Hayes C, Persaud J, Roberts R. Usefulness of brain as a positive control for the human tumor clonogenic assay. Inv New Drugs. 1:1983;277-281.
17. Salmon S E, Hamburger A W, Soehnien B, Durie B G, Alberts D S, Moon T E. Quantitation of differential sensitivity of human tumor stem cells to anti-cancer drugs. N Engl J Med. 298:1978;1321-1327.
18. Salmon S E, Young L, Leibovitz J, Thomson S, Einspahr J, Tong T, Moon T E. Evaluation of an automated image analysis system for counting human tumor colonies. Int J Cell Cloning. 2:1984;142-160.
19. Tanigawa N, Kern D H, Hikasa Y, Morton D L. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar. Cancer Res. 42:1982;2159-2164.
20. Alberts D S, Fanta P T, Running K L, Adair L P Jr, Garcia D J, Liu-Stevens R, Salmon S E. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers. Cancer Chemother Pharmacol. 39:1997;493-497.
21. Goel R, Andrews P A, Pfeifle C E, Abramson S, Kirmani S, Howell S B. Comparison of the pharmacokinetics of ultra-filterable cisplatin species detectable by derivatization with diethyldithiocarbamate of atomic absorption spectroscopy. Eur J Cancer. 26:1990;21-27.
22. Sasaki Y, Tamura T, Eguchji K, Shinkai T, Fujiwara Y, Fukuda M, Obe Y, Bungo M, Horichi N, Niimi S. Pharmacokinetics of (glycolato-O-O. Cancer Chemother Pharmacol. 23:1989;243-246.
23. van Warmerdam W C, Rodenhuis S, van Telligen O, Maes R AA, Beijen J H. Validation of a limited sampling model for carboplatin in a high-dose chemotherapy combination. Cancer Chemother Pharmacol. 35:1994;179-181.
24. McNemar Q. Note on the sampling error of the difference between the correlated proportions or percentages. Psychometrika. 12:1947;153-157.
25. Alberts D S, Salmon S E, Chen H SG, Moon T E, Young L, Surwit E A. Pharmacologic studies of anticancer drugs with the human tumor stem cell assay. Cancer Chemother Pharmacol. 6:1981;253-264.
26. Bonomi P, Blessing J A, Stehman F B, DiSaia P J, Walton L, Major F J. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol. 3:1985;1079-1085.
27. McGuire W P, Arseneau J, Blessing J A, DiSaia P J, Hatch K D, Given F T, Teng N NH, Creasman W T. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol. 7:1989;1462-1468.
28. Ariyoshi Y, Ota K, Wakui A, Majima H, Nittani H, Ogawa M, Inuyama Y, Yoshida O, Taguchi T, Kimura I, Kato T. Phase I study of (glycolato-O-O. Proc Am Soc Clin Oncol. 7:1988;59.